Staphylococcus aureus bacteremia and endocarditis
Feng-Yee Chang
Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
Staphylococcus aureus bacteremia is a serious and common disease often associated with infective endocarditis. It occurs in both healthy, immunologically competent people in the community and compromised patients in the hospitals. For S. aureus bacteremia, questions on clinical issues such as antimicrobial treatment are raised. Is nafcillin/oxacillin superior to vancomycin? Does the addition of rifampin improve outcome? Does addition of aminoglycoside improve the outcome? Does increasing duration of therapy (> 4 weeks versus
J Microbiol Immunol Infect 2000;33:63-68.
|
This website is designed and maintained by Scientific Communications International Limited on behalf of the Chinese Society of Microbiology, the Chinese Society of Immunology, the Infectious Diseases Society of the Republic of China, and the
Taiwan Society of Parasitology
|
|
|
|